Evidence Intelligence Dashboard
Understand diabetes research—without reading every study
| Intervention | Outcome | Strength |
|---|---|---|
| Lifestyle intervention for prediabetes | Body weight | Emerging |
| Synchronous online type 1 diabetes psychoeducational program for school staff | Fasting blood sugar (FBS) | Emerging |
| Digital physician-pharmacist collaborative care | HbA1c | Emerging |
Explore Diabetes Evidence Topics
Deep dives into key evidence areas with comprehensive research synthesis
Glycemic Control
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
Weight Loss
Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
HbA1c Reduction
Evidence related to lowering or improving HbA1c/A1C in diabetes management.
Diabetic Kidney Disease
Evidence related to diabetic kidney disease, albuminuria, kidney function, nephropathy progression, end-stage renal disease, and kidney-protective diabetes treatments.
Prediabetes
Evidence related to preventing or delaying type 2 diabetes, reducing diabetes incidence, and improving metabolic risk in people with prediabetes.
Insulin Resistance
Evidence related to improving insulin resistance, insulin sensitivity, fasting insulin, C-peptide levels, and beta-cell function in diabetes and prediabetes.
How Diabetes Evidence Connects
Every study contributes evidence linking interventions and outcomes. deDiabetes organizes those findings into connected evidence topics so you can move from broad questions to supporting research.
Featured Evidence Insights
Strongest findings from our evidence intelligence analysis
SGLT2 Inhibitors → Glycemic Control
Dapagliflozin shows moderate improvement in HbA1c with consistent results (emerging research, 4 studies).
Emerging evidence suggests further research needed.
Metformin Therapies → Glycemic Control
Metformin shows moderate improvement in HbA1c with consistent results (emerging research, 3 studies).
Emerging evidence suggests further research needed.
GLP-1 Receptor Agonists → Body Weight
Semaglutide shows strong improvement in Body weight with consistent results (emerging research, 2 studies).
Moderate evidence warrants consideration with clinical context.
Insulin Therapies → Glycemic Control
Insulin degludec shows strong improvement in Blood glucose with consistent results (emerging research, 2 studies).
Emerging evidence suggests further research needed.
Low-Carbohydrate Diets → Body Weight
Low-carbohydrate diet shows strong improvement in Body weight with consistent results (emerging research, 2 studies).
Emerging evidence suggests further research needed.
Low-Carbohydrate Diets → Glycemic Control
Low-carbohydrate diet shows strong improvement in HbA1c with consistent results (emerging research, 2 studies).
Emerging evidence suggests further research needed.
Evidence Collections
High-value evidence organized by strength, consistency, and research focus
Top Evidence Signals
Highest-ranked evidence pairs currently in database
- •Semaglutide → Body weight
- •Semaglutide → BMI
Most Consistent Results
Evidence with agreement across multiple studies
- •Metformin → HbA1c
- •Semaglutide → Body weight
Most Studied Interventions
Interventions with the broadest evidence base
- •Dapagliflozin
- •Resistance training
Emerging Evidence
Promising early-stage research areas
- •Metformin → HbA1c
- •Dapagliflozin → HbA1c
New Evidence This Month
Recently published research
- •Dapagliflozin plus gliclazide combination improves blood sugar control in type 2 diabetes
- •Structured case management may improve recovery after CABG in older adults with type 2 diabetes
Latest Updates
Recently added studies and evidence pairs
Structured case management may improve recovery after CABG in older adults with type 2 diabetes
Newer diabetes drugs show stronger weight and blood sugar benefits in prediabetes
Needle-free insulin injection improves blood sugar control and reduces pain in hospitalized type 2 diabetes patients
Evidence Comparison Table
Highest-ranked intervention and outcome relationships from the evidence graph
Ranked using evidence strength, validation, consistency, and study depth
| # | Intervention | Outcome | Effectiveness | Evidence Strength | Studies |
|---|---|---|---|---|---|
| 1 | Lifestyle intervention for prediabetes | Body weight | moderate_positive | Emerging | 0 |
| 2 | Synchronous online type 1 diabetes psychoeducational program for school staff | Fasting blood sugar (FBS) | strong_positive | Emerging | 0 |
| 3 | Digital physician-pharmacist collaborative care | HbA1c | strong_positive | Emerging | 0 |
| 4 | Dapagliflozin | HbA1c | moderate_positive | Emerging | 0 |
| 5 | Structured multidisciplinary case management | HbA1c | strong_positive | Emerging | 0 |
| 6 | Dapagliflozin | Fasting blood sugar (FBS) | strong_positive | Emerging | 0 |
| 7 | Needle-free injection | Time in range | strong_positive | Emerging | 0 |
| 8 | Lifestyle intervention for prediabetes | Fasting blood sugar (FBS) | weak_positive | Emerging | 0 |
| 9 | Lifestyle intervention for prediabetes | HbA1c | moderate_positive | Emerging | 0 |
| 10 | Dapagliflozin | Body weight | weak_positive | Emerging | 0 |
| 11 | Resistance training | Fasting blood sugar (FBS) | weak_positive | Limited | 0 |
| 12 | Resistance training | HbA1c | weak_positive | Limited | 0 |
How to Read Evidence Cards
Each card summarizes one intervention → outcome relationship
Cards combine study count, effectiveness, consistency, and evidence strength into a quick research intelligence snapshot.
Metformin → Improved Glycemic Control
Strong evidence supports metformin as first-line therapy for improving blood sugar control in type 2 diabetes.
Backed by decades of research and consistent findings across diverse populations.
Evidence Strength
Overall confidence based on study quality, consistency, and depth
Effectiveness
Observed direction and magnitude of outcomes
Consistency
Whether multiple studies agree
Study Count
Number of supporting research studies
Strength Meter
Quick visual confidence indicator
Evidence scores are generated from aggregated research analysis and are not medical advice.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.